Showing results (151-160 of 161) with videos related to
Sort By:
Pageof 17
Journal of the National Cancer Institute|March 2, 1999
Sentinel lymph node biopsy and axillary dissection in breast cancer: results in a large seriesU Veronesi, G Paganelli, G Viale, et al.Journal of Endocrinological Investigation|May 14, 2008
Usefulness of [111In-DTPA0] octreotide scintigraphy in a family with von Hippel-Lindau diseaseM Pulcrano, L Camera, L Pagano, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 10, 2008
The value of radiotherapy on metastatic internal mammary nodes in breast cancer. Results on a large seriesU Veronesi, P Arnone, P Veronesi, et al.Scientific Reports|November 16, 2017
Circulating androgen receptor combined with 18F-fluorocholine PET/CT metabolic activity and outcome to androgen receptor signalling-directed therapies in castration-resistant prostate cancerV Conteduca, E Scarpi, P Caroli, et al.Biomed Research International|July 19, 2013
Kidney dosimetry in ¹⁷⁷Lu and ⁹⁰Y peptide receptor radionuclide therapy: influence of image timing, time-activity integration method, and risk factorsF Guerriero, M E Ferrari, F Botta, et al.ESMO Open|June 17, 2021
Peptide receptor radionuclide therapy in patients with metastatic progressive pheochromocytoma and paraganglioma: long-term toxicity, efficacy and prognostic biomarker data of phase II clinical trialsS Severi, A Bongiovanni, M Ferrara, et al.Ecancermedicalscience|January 26, 2012
IART (Intra-Operative Avidination for Radionuclide Therapy) for accelerated radiotherapy in breast cancer patients. Technical aspects and preliminary results of a phase II study with 90Y-labelled biotinG Paganelli, C De Cicco, M E Ferrari, et al.Physics in Medicine and Biology|November 9, 2013
Use of the FLUKA Monte Carlo code for 3D patient-specific dosimetry on PET-CT and SPECT-CT imagesF Botta, A Mairani, R F Hobbs, et al.British Journal of Cancer|April 3, 2003
Novel antitenascin antibody with increased tumour localisation for Pretargeted Antibody-Guided RadioImmunoTherapy (PAGRIT)R De Santis, A M Anastasi, V D'Alessio, et al.Ecancermedicalscience|January 26, 2012
Institutional guidelines and ongoing studies in management of liver tumours: the experience of the European Institute of OncologyR Biffi, F Orsi, M G Zampino, et al.Pageof 17